$10.48
+0.02 (+0.19%)
Open$10.49
Previous Close$10.46
Day High$10.51
Day Low$10.45
52W High$10.69
52W Low$10.11
Volume—
Avg Volume57.0K
Market Cap392.45M
P/E Ratio38.81
EPS$0.50
SectorN/A
Analyst Ratings
Sell
9 analysts
Price Target
+217.3% upside
Current
$10.48
$10.48
Target
$33.25
$33.25
$21.69
$33.25 avg
$38.82
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 229.75M | 221.12M | 203.42M |
| Net Income | 18.67M | 19.49M | 13.94M |
| Profit Margin | 8.1% | 8.8% | 6.9% |
| EBITDA | 31.30M | 28.96M | 26.35M |
| Free Cash Flow | 15.11M | 9.40M | 12.42M |
| Rev Growth | +0.0% | -7.2% | +5.6% |
| Debt/Equity | 0.24 | 0.28 | 0.30 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $6.66 | -0.60% | — | 4.19B |
| PICS | Pics Nv | $10.63 | -0.09% | 6.1 | 1.37B |
| DMII | Drugs Made In America Acquis | $10.09 | +0.40% | 74.6 | 640.19M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.67 | -0.19% | 35.3 | 334.79M |
| CEPF | Cantor Equity Partners-Cl A | $10.39 | +0.10% | 57.5 | 591.76M |